1900 M Street, NW 3rd Floor
Washington, DC 20036
The Commonwealth Fund published a To the Point blog post detailing the incremental steps that Congress has taken on policies that would lower drug costs for patients.
If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.
Are you innovating? Interested in creating real and lasting change? See how Waxman can help.
Get In Touch